Patent US4405627A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4405627A Expired / Lapsed US ⏱️ 0.0 years remaining

Diphenylpropylamino-pyridine compounds useful as medicines

Assignee: Rbs Pharma (Roger Bellon Schoum) SpA
•
Filing: 1981-05-07
•
Granted: 1983-09-20
•
Expires: 2001-05-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel diphenylpropylamino-pyridine derivatives of general formula: ##STR1## are described and the spasmolytic, miorelaxing and local in vitro and in vivo anesthetic properties of some of them are given on the basis of experimental data as resulting from tests carried out on animals and isolated organs. The synthetized and tested compounds, which are endowed with a low toxicity, reduce the spontaneous motility and the drug-induced contractions, without anticholinergic side-effects at a central level.

Inventors

  • 👤 Paolo Masi
  • 👤 Angela Monopoli
  • 👤 Adone C. Saravalle
  • 👤 Cesare Zio

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 15:37
CPC Classifications
C; C07; C07D; C07D213/00; C07D213/02; C07D213/04; C07D213/60; C07D213/72; C07D213/75

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 119 words
A method of treating spastic syndromes in the muscular tissues of mammals comprising administering to the mammal a unitary dosage of from about 20 to 100 mg per kilogram of body weight of a compound having the formula: ##STR4## wherein the diphenylpropylamino group is bound at position 2 or 3 of the pyridine ring; R is selected from the group consisting of hydrogen, a lower linear or branched alkyl group having from 1 to 4 carbon atoms and arakyl; X is selected from chlorine, bromine and iodine, Y is selected from hydrogen, fluorine, bromine, chlorine and methoxy; Z is Oxygen or H 2 and n is zero or 1, provided that Z is H 2 when n is one.
Claim 2
Independent Claim 119 words
A method of treating spastic syndromes in the muscular tissues of mammals comprising administering to the mammal a unitary dosage of from about 20 to 100 mg per kilogram of body weight of a compound having the formula: ##STR4## wherein the diphenylpropylamino group is bound at position 2 or 3 of the pyridine ring; R is selected from the group consisting of hydrogen, a lower linear or branched alkyl group having from 1 to 4 carbon atoms and arakyl; X is selected from chlorine, bromine and iodine, Y is selected from hydrogen, fluorine, bromine, chlorine and methoxy; Z is Oxygen or H 2 and n is zero or 1, provided that Z is H 2 when n is one.
Claim 3
Dependent Claim 25 words
A method according to claim 1, wherein the said compound has the following formula: ##STR5## and wherein R, X and n are as therein defined.
Claim 4
Dependent Claim 11 words
A method according to claim 1, wherein said compounds is N-(2'-pyridyl)-3,3-diphenylpropylamine.
Claim 5
Dependent Claim 11 words
A method according to claim 1, wherein said compound is N-(3'-pyridyl)-3,3-diphenylpropylamine.
Claim 6
Dependent Claim 12 words
A method according to claim 1, wherein said compound is 2-(3',3'-diphenylpropyl-1'-amino)-1-methylpyridinium iodide.

References Cited (Backward Citations)

US4180670A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1986-09-19 1987-03-21 1987-09-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1990-09-19 1991-03-21 1991-09-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1994-09-19 1995-03-21 1995-09-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag